1. Home
  2. TRNR vs PRFX Comparison

TRNR vs PRFX Comparison

Compare TRNR & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Interactive Strength Inc.

TRNR

Interactive Strength Inc.

N/A

Current Price

$1.76

Market Cap

2.8M

Sector

Technology

ML Signal

N/A

Logo PainReform Ltd.

PRFX

PainReform Ltd.

BUY

Current Price

$0.75

Market Cap

3.1M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
TRNR
PRFX
Founded
2017
2007
Country
United States
Israel
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
3.1M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
TRNR
PRFX
Price
$1.76
$0.75
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $10.00
N/A
AVG Volume (30 Days)
31.7K
★ 34.3K
Earning Date
11-16-2026
09-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $11,530,000.00
N/A
Revenue This Year
$117.64
N/A
Revenue Next Year
$10.59
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 114.31
N/A
52 Week Low
$1.70
$0.58
52 Week High
$3,378.70
$5.39

Technical Indicators

Market Signals
Indicator
TRNR
PRFX
Relative Strength Index (RSI) 24.04 36.52
Support Level N/A $0.58
Resistance Level $3.23 $1.28
Average True Range (ATR) 0.12 0.05
MACD 0.23 -0.01
Stochastic Oscillator 14.08 30.52

Price Performance

Historical Comparison
TRNR
PRFX

About TRNR Interactive Strength Inc.

Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.

About PRFX PainReform Ltd.

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.

Share on Social Networks: